Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ELAGOLIX SODIUM COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2022/222886
Kind Code:
A1
Abstract:
The present invention relates to an elagolix sodium composition. Specifically, disclosed is an elagolix sodium composition, which comprises: elagolix sodium as shown in formula (I), and a pharmaceutically acceptable alkalizing agent, filler and adhesive. The alkalizing agent comprises a substance selected from among the following group: an alkali metal hydroxide, an alkali metal salt, an organic base, an amino acid, an alkaline earth metal salt, and an alkaline earth metal oxide. The described composition avoids the use of a carbonate while having dissolution performance that is similar to or better than an original preparation, thereby reducing the generation of carbon dioxide in the stomach. In addition, the preparation/composition in the present invention has fewer impurities and has higher stability during placement.

Inventors:
CHALLA GOPI KRISHNA (CN)
CHI ZHIQIANG (CN)
YAN LI (CN)
Application Number:
PCT/CN2022/087432
Publication Date:
October 27, 2022
Filing Date:
April 18, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI QISHENGHEYAN PHARMACEUTICALS CO LTD (CN)
SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP CO LTD (CN)
International Classes:
A61K31/513; A61K9/28; A61K47/02; A61K47/18; A61P5/02
Domestic Patent References:
WO2018189213A12018-10-18
WO2021180862A12021-09-16
Foreign References:
CN111698992A2020-09-22
CN111246850A2020-06-05
CN113384581A2021-09-14
US11273128B12022-03-15
Other References:
LAMB YVETTE N.: "Elagolix: First Global Approval", DRUGS, ADIS INTERNATIONAL LTD., NZ, vol. 78, no. 14, 1 September 2018 (2018-09-01), NZ , pages 1501 - 1508, XP055806347, ISSN: 0012-6667, DOI: 10.1007/s40265-018-0977-4
Attorney, Agent or Firm:
XU&PARTNERS, LLC. (CN)
Download PDF: